Wei Wang

Dr. Wei Wang


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 July 2022 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
XZXiaohui Zan
Xiaohui Zan
HHHaibi Huang
Haibi Huang
YGYu Guo
Yu Guo
DDDongdong Di
Dongdong Di
CFCun Fu
Cun Fu
WWWei Wang
Wei Wang
Background: The outbreak of Lumpy skin disease (LSD) in cattle caused by LSD virus (LSDV) was first reported in August 2019 in China. Since then, several LSD outbreaks have been reported in seven different provinces of China. Until now, several Lumpy skin disease virus (LSDV) strains from China have been reported and sequenced including LSDV/Xinjiang/2019 (MN598005.1), China/GD01/2020 (MW355944.1), and LSDV/Hongkong/2021 (MW732649.1). In October 2020, more than 1,700 cattle imported from Chile arrived in Xilingol, Inner Mongolia, and were diagnosed with LSD. Currently, limited data on the origin of the virus is available. Methods: Nucleotide sequences of the ORF11, ORF36, ORF74, ORF117, ORF126 genes and the complete genome of LSDV strains and isolates were downloaded from NCBI database. MEGA7.0 was used to perform phylogenetic analysis with Neighbor-Joining (NJ). DNASTAR software is used to analyze homologous comparison analysis with related genes of reference strains included in Genbank. Results: Compared with other strains isolated from China, the results of full genome sequence analysis showed the LSDV/NMG/2020 strain belonged to the recombinant strains. The LSDV/NMG/2020 strain is different from the current LSDV field isolates in Africa, the Middle East, Europe, and the newly emerged LSDV Russia variants. Based on the identities of P32, RPO30, EEV, GPCR and LSDV117 genes (99.8%, 99%, 99.8%, 99% and 98.7%), the sub-cluster recombinant containing LSDV/NMG/2020 strain is phylogenetically closer to the Russia strain (Saratov/2017). Conclusions: In this study, we reported a new isolated LSDV strain named LSDV/NMG/2020. The results of genomic characterization and phylogenetic analysis demonstrated that the LSDV/NMG/2020 isolate was a vaccine-like recombinant strain.

1 December 2023 in Virologica Sinica
Verified
Journal Article
Open access
XZXiaohui Zan
Xiaohui Zan
SWShirong Wang
Shirong Wang
TZTianqi Zhang
Tianqi Zhang
YLYing Li
Ying Li
CZChunge Zhang
Chunge Zhang
WWWei Wang
Wei Wang
• Akabane ​virus ​sub-lineage ​genogroup ​Ib ​was ​identified ​and ​isolated ​in ​China ​for ​the ​first ​time. • The suckling mice showed clinical symptoms after intracerebrally infected with LK07 strain. • Viral antigen was detected in brain of mice infected with LK07 strain via IC, IP and SC routes.

18 May 2024 in BMC Veterinary Research
Verified
Journal Article
Open access
PDF file
FZFan Zhang
Fan Zhang
CCChunxia Chai
Chunxia Chai
RNRui Niu
Rui Niu
YDYun Diao
Yun Diao
YZYanyan Zhou
Yanyan Zhou
WWWei Wang
Wei Wang
Background: Bovine coronavirus (BCoV) is implicated in severe diarrhea in calves and contributes to the bovine respiratory disease complex; it shares a close relationship with human coronavirus. Similar to other coronaviruses, remarkable variability was found in the genome and biology of the BCoV. In 2022, samples of feces were collected from a cattle farm. A virus was isolated from 7-day-old newborn calves. In this study, we present the genetic characteristics of a new BCoV isolate. The complete genomic, spike protein, and nucleocapsid protein gene sequences of the BCoV strain, along with those of other coronaviruses, were obtained from the GenBank database. Genetic analysis was conducted using MEGA7.0 and the Neighbor-Joining (NJ) method. The reference strains’ related genes were retrieved from GenBank for comparison and analysis using DNAMAN. Results: The phylogenetic tree and whole genome consistency analysis showed that it belonged to the GIIb subgroup, which is epidemic in Asia and America, and was quite similar to the Chinese strains in the same cluster. Significantly, the S gene was highly consistent with QH1 (MH810151.1) isolated from yak. This suggests that the strain may have originated from interspecies transmission involving mutations of wild strains. The N gene was conserved and showed high sequence identity with the epidemic strains in China and the USA. Conclusions: Genetic characterization suggests that the isolated strain could be a new mutant from a wild-type lineage, which is in the same cluster as most Chinese epidemic strains but on a new branch.

1 May 2021 in Microbial Pathogenesis
Verified
Journal Article
Closed access
YMYanhua Ma
Yanhua Ma
YWYan Wang
Yan Wang
XZXiaohui Zan
Xiaohui Zan
YWYouzhi Wu
Youzhi Wu
JWJialei Wang
Jialei Wang
WWWei Wang
Wei Wang

14 September 2022 in Animals
Verified
Journal Article
Open access
PDF file
CCchunxia chai
chunxia chai
JZJinlong Zhang
Jinlong Zhang
YZYanyan Zhou
Yanyan Zhou
HYHua Yin
Hua Yin
FZFan Zhang
Fan Zhang
WWWei Wang
Wei Wang
Oncolytic viral therapy is a promising treatment approach for a variety of tumor forms. Although a number of studies have demonstrated that the pseudorabies virus (PRV) may be applied as an oncolytic carrier, the anti-colorectal cancer impact of the virus and the mechanism of its cytotoxic effect remain elusive. In this study, the replication capacity and cell activity of PRV attenuated live vaccines Bartha K61 and HB98 in HCT-8 cells in vitro were investigated. Next, the antitumor ability and safety were evaluated in a mouse model of HCT-8 tumor transplantation. Both PRV strains were able to suppress tumor growth and HB98 showed higher safety and efficiency than the Bartha K61 strain. Finally, flow cytometry and immunohistochemistry examination were performed to investigate its possible cytotoxic mechanism. The results showed that PRV inhibited tumor proliferation both in vitro and in vivo by inducing apoptosis. In summary, our study discovered for the first time that the live attenuated PRV has an oncolytic effect on HCT-8 cells with high efficacy and safety.

27 June 2024 in Veterinary Research
Verified
Journal Article
Open access
PDF file
YMYanhua MA
Yanhua MA
JWJialei Wang
Jialei Wang
YWYouzhi Wu
Youzhi Wu
XZXiaohui Zan
Xiaohui Zan
YWYan Wang
Yan Wang
WWWei Wang
Wei Wang
Respiratory diseases constitute a major health problem for ruminants, resulting in considerable economic losses throughout the world. Parainfluenza type 3 virus (PIV3) is one of the most important respiratory pathogens of ruminants. The pathogenicity and phylogenetic analyses of PIV3 virus have been reported in sheep and goats. However, there are no recent studies of the vaccination of sheep or goats against PIV3. Here, we developed a purified inactivated ovine parainfluenza virus type 3 (OPIV3) vaccine candidate. In addition, we immunized sheep with the inactivated OPIV3 vaccine and evaluated the immune response and pathological outcomes associated with OPIV3 TX01 infection. The vaccinated sheep demonstrated no obvious symptoms of respiratory tract infection, and there were no gross lesions or pathological changes in the lungs. The average body weight gain significantly differed between the vaccinated group and the control group (P < 0.01). The serum neutralization antibody levels rapidly increased in sheep post-vaccination and post-challenge with OPIV3. Furthermore, viral shedding in nasal swabs and viral loads in the lungs were reduced. The results of this study suggest that vaccination with this candidate vaccine induces the production of neutralizing antibodies and provides significant protection against OPIV3 infection. These results may be helpful for further studies on prevention and control strategies for OPIV3 infections.